Estrogenic antagonism of metabolic effects of administered growth hormone.
D000328:Adult; D001862:Bone Resorption / Q000187:drug effects; D002118:Calcium / Q000652:urine; D002986:Clinical Trials as Topic; D004966:Estrogens, Conjugated (USP) / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005243:Feces / Q000032:analysis; D013006:Growth Hormone / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000378:metabolism; D010024:Osteoporosis / Q000188:drug therapy / Q000378:metabolism; D010758:Phosphorus / Q000097:blood
D004966:Estrogens, Conjugated (USP); D010758:Phosphorus; D004997:Ethinyl Estradiol; D013006:Growth Hormone; D009584:Nitrogen; D006909:Hydroxyproline; D002118:Calcium